Xeris Pharmaceuticals
XERS74
$3.35arrow_drop_down3.72%-$0.13
High Growth
Penny Stock
XERS74
$3.35
arrow_drop_down3.72%Performance History
| Key Stats | |
|---|---|
| Open | $3.47 |
| Prev. Close | $3.49 |
| EPS | -0.43 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $500.16M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 3.32 | 3.50 |
| 52 Week Range | 1.46 | 3.86 |
| Ratios | |
|---|---|
| EPS | -0.43 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Xeris Pharmaceuticals (XERS)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Paul R. Edick
- Headquarters
- Chicago
- Employees
- 355
- Exchange
- NASDAQ
Keep an eye on Xeris Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Xeris Pharmaceuticals 's (XERS) price per share?
The current price per share for Xeris Pharmaceuticals (XERS) is $3.35. The stock has seen a price change of -$0.13 recently, indicating a -3.72% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Xeris Pharmaceuticals (XERS)?
For Xeris Pharmaceuticals (XERS), the 52-week high is $3.87, which is 15.2% from the current price. The 52-week low is $1.46, the current price is 129.79% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Xeris Pharmaceuticals (XERS) a growth stock?
Xeris Pharmaceuticals (XERS) has shown an average price growth of -5.18% over the past three years. It has received a score of 79 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Xeris Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Xeris Pharmaceuticals (XERS) stock price performance year to date (YTD)?
As of the latest data, Xeris Pharmaceuticals (XERS) has a year-to-date price change of 48.12%. Over the past month, the stock has experienced a price change of 8.58%. Over the last three months, the change has been 21.56%. Over the past six months, the figure is 59%. Looking at a longer horizon, the five-year price change stands at -57.8%.
help
Is Xeris Pharmaceuticals (XERS) a profitable company?
Xeris Pharmaceuticals (XERS) has a net income of -$62.26M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 82.52% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -23.76% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $163.91M, with a revenue growth rate of 48.68%, providing insight into the company's sales performance and growth. The gross profit is $135.27M. Operating income is noted at -$44.01M. Furthermore, the EBITDA is -$33.06M.
help
What is the market capitalization of Xeris Pharmaceuticals (XERS)?
Xeris Pharmaceuticals (XERS) has a market capitalization of $500.17M. The average daily trading volume is 3.37, indicating the stock's liquidity and investor engagement.